Aqr Capital Management LLC Ocular Therapeutix, Inc Transaction History

Aqr Capital Management LLC

  • $58.2 Billion
  • Q1 2024

A detailed history of Aqr Capital Management LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 11,755 shares of OCUL stock, worth $80,404. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,755
Previous 52,228 77.49%
Holding current value
$80,404
Previous $232,000 54.31%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$3.85 - $10.93 $155,821 - $442,369
-40,473 Reduced 77.49%
11,755 $106,000
Q4 2023

Feb 14, 2024
SELL
$2.08 - $4.52 $31,150 - $67,691
-14,976 Reduced 22.28%
52,228 $232,000
Q3 2023

Nov 14, 2023
BUY
$3.14 - $5.04 $78,418 - $125,868
24,974 Added 59.14%
67,204 $211,000
Q2 2023

Aug 14, 2023
SELL
$4.6 - $7.64 $1,324 - $2,200
-288 Reduced 0.68%
42,230 $217,000
Q1 2023

May 15, 2023
SELL
$2.79 - $6.27 $195,556 - $439,476
-70,092 Reduced 62.24%
42,518 $224,000
Q4 2022

Feb 14, 2023
BUY
$2.61 - $4.41 $260,029 - $439,359
99,628 Added 767.43%
112,610 $316,000
Q3 2022

Nov 14, 2022
SELL
$4.09 - $6.5 $91,452 - $145,340
-22,360 Reduced 63.27%
12,982 $54,000
Q2 2022

Aug 15, 2022
BUY
$3.01 - $5.22 $20,910 - $36,263
6,947 Added 24.47%
35,342 $142,000
Q1 2022

May 16, 2022
BUY
$4.83 - $7.35 $32,240 - $49,061
6,675 Added 30.73%
28,395 $141,000
Q4 2021

Feb 14, 2022
SELL
$6.16 - $12.07 $264,645 - $518,551
-42,962 Reduced 66.42%
21,720 $151,000
Q3 2021

Nov 15, 2021
BUY
$9.7 - $14.34 $58,267 - $86,140
6,007 Added 10.24%
64,682 $647,000
Q2 2021

Aug 16, 2021
SELL
$13.43 - $19.16 $85,978 - $122,662
-6,402 Reduced 9.84%
58,675 $832,000
Q1 2021

May 17, 2021
BUY
$15.82 - $22.11 $257,723 - $360,194
16,291 Added 33.39%
65,077 $1.07 Million
Q4 2020

Feb 16, 2021
SELL
$7.91 - $22.95 $61,927 - $179,675
-7,829 Reduced 13.83%
48,786 $1.01 Million
Q3 2020

Nov 16, 2020
SELL
$7.36 - $9.87 $122,139 - $163,792
-16,595 Reduced 22.67%
56,615 $431,000
Q2 2020

Aug 17, 2020
BUY
$4.67 - $8.95 $341,890 - $655,229
73,210 New
73,210 $610,000
Q4 2017

Feb 14, 2018
SELL
$3.73 - $6.37 $79,284 - $135,400
-21,256 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$5.28 - $6.88 $112,231 - $146,241
21,256
21,256 $131,000

Others Institutions Holding OCUL

# of Institutions
148
Shares Held
123M
Call Options Held
185K
Put Options Held
507K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $526M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email